NELSEN ROBERT Insider Trading Activity

Average Profitability
16.8%
Insider Buys Quantity
6
Insider Buys Sum
$84.3M
Insider Sells Quantity
7
Insider Sells Sum
$20.75M

Insider Activity of NELSEN ROBERT

Biography of NELSEN ROBERT

No biography is available at this moment.

2025-08-01PurchasePrime Medicine, Inc.
PRME
3.03M
1.988%
$3.30$10M-9.03%
2024-02-15PurchasePrime Medicine, Inc.
PRME
3.2M
4.6348%
$6.25$20M-43.72%
2024-02-08PurchaseSana Biotechnology, Inc.
SANA
1.09M
0.5382%
$5.50$6M-14.94%
2022-10-24PurchasePrime Medicine, Inc.
PRME
director
400,000
1.5758%
$17.00$6.8M-3.68%
2019-10-16PurchaseVir Biotechnology, Inc.
VIR
2M
8.9051%
$20.00$40M+115.34%
2017-03-06SaleAgios Pharmaceuticals, Inc.
AGIO
director
40
<0.0001%
$49.43$1,977+18.25%
2017-03-03SaleAgios Pharmaceuticals, Inc.
AGIO
director
40,559
0.0957%
$50.85$2.06M+15.64%
2017-02-28SaleAgios Pharmaceuticals, Inc.
AGIO
director
47,859
0.1163%
$49.77$2.38M+21.08%
2017-02-27SaleAgios Pharmaceuticals, Inc.
AGIO
director
195,223
0.4516%
$49.26$9.62M+16.4%
2017-02-23SaleAgios Pharmaceuticals, Inc.
AGIO
director
50,996
0.1219%
$47.90$2.44M+23.2%
2017-02-22SaleAgios Pharmaceuticals, Inc.
AGIO
director
47,938
0.1155%
$49.91$2.39M+19.05%
2017-02-21SaleAgios Pharmaceuticals, Inc.
AGIO
director
36,430
0.0867%
$50.73$1.85M+15.51%
2013-10-04PurchaseFate Therapeutics, Inc.
FATE
1.67M
6.8738%
$6.00$10M-9.51%
Total: 13
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.